TCT23 Late-breakers: Full Schedule Announced
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
Source: dicardiology.com
Stay updated with breaking news from Stephan Windecker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
Early results promising with DynamX bioadaptor, though traditional BRS hasn't been abandoned
It’s too early to know if a device that uncouples itself with time, leaving behind a healthier, supple vessel, can fill an unmet need.
The pivotal TR trial of Evoque, now enrolling, will clarify just how well patients do with valve replacement vs pills alone.
The society is also actively looking eastward for future meetings